1 documents found
Head: Скрипніков Андрій Миколайович. Additional observational study lasting 2 months to evaluate safety in patients with agitation, fl "related dementia of the Alzheimer's type, previously treated brekspirazolom (OPC-34712) or placebo in double-blind phase 3 study.
Ukrainian medical stomatological Academy. № 0117U004780
1 documents found
Updated: 2026-03-29
